Literature DB >> 22789562

Prevalence and predictors of depression among participants with glaucoma in a nationally representative population sample.

Sophia Y Wang1, Kuldev Singh, Shan C Lin.   

Abstract

PURPOSE: To investigate the prevalence of and risk factors for depression among participants with glaucoma and the predictive value of glaucoma for depression.
DESIGN: Cross-sectional study.
METHODS: This study included 6760 participants in the National Health and Nutrition Examination Survey (NHANES) between 2005 and 2008, aged ≥40 years, who reported a presence or absence of glaucoma. Demographic and disease-related information was obtained by interview. Self-reported measures of vision were ascertained via items from the Visual Function Questionnaire (VFQ-25). Participants underwent visual acuity examination, fundus photography, and visual field testing with screening frequency-doubling technology (FDT N-30-5). The main outcome was presence of depression, as determined by a score ≥10 on the Patient Health Questionnaire-9 (PHQ-9).
RESULTS: Prevalence of depression among participants with and without glaucoma was 10.9% (SEM 2.2%) and 6.9% (SEM 0.62%), respectively. While the presence of glaucoma was significantly associated with depression after adjustment for demographic factors (OR 1.80, 95% CI 1.16-2.79), this association was not significant after adjustment for self-reported general health condition (OR 1.35, 95% CI 0.822-2.23). Among participants with glaucoma, objective measures of glaucoma severity were not significant predictors for depression. However, several self-reported measures of visual function were significantly associated with depression.
CONCLUSIONS: Glaucoma is a significant predictor of depression after adjustment for demographic factors and multiple comorbidities, but not after adjustment for self-reported general health condition. Among participants with glaucoma, self-reported measures of vision were significant risk factors for depression, whereas objective measures of vision were not.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22789562      PMCID: PMC3422443          DOI: 10.1016/j.ajo.2012.03.039

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  19 in total

1.  Development of the 25-item National Eye Institute Visual Function Questionnaire.

Authors:  C M Mangione; P P Lee; P R Gutierrez; K Spritzer; S Berry; R D Hays
Journal:  Arch Ophthalmol       Date:  2001-07

Review 2.  Open-angle glaucoma -- an epidemiologic overview.

Authors:  M Cristina Leske
Journal:  Ophthalmic Epidemiol       Date:  2007 Jul-Aug       Impact factor: 1.648

3.  Topical beta-blockers are not associated with an increased risk of treatment for depression.

Authors:  Igor Kaiserman; Nadia Kaiserman; Asher Elhayany; Shlomo Vinker
Journal:  Ophthalmology       Date:  2006-07       Impact factor: 12.079

4.  Influence of glaucomatous visual field loss on health-related quality of life.

Authors:  P Gutierrez; M R Wilson; C Johnson; M Gordon; G A Cioffi; R Ritch; M Sherwood; K Meng; C M Mangione
Journal:  Arch Ophthalmol       Date:  1997-06

5.  Depression in patients with glaucoma as measured by self-report surveys.

Authors:  M Roy Wilson; Anne L Coleman; Fei Yu; Irene Fong Sasaki; Eric G Bing; Matthew H Kim
Journal:  Ophthalmology       Date:  2002-05       Impact factor: 12.079

6.  Prevalence of cognitive impairment, depression, and anxiety symptoms among older adults with glaucoma.

Authors:  Brian P Yochim; Anne E Mueller; Katherine D Kane; Malik Y Kahook
Journal:  J Glaucoma       Date:  2012 Apr-May       Impact factor: 2.503

7.  Depressive symptomatology, medication persistence, and associated healthcare costs in older adults with glaucoma.

Authors:  Sujata S Jayawant; Monali J Bhosle; Roger T Anderson; Rajesh Balkrishnan
Journal:  J Glaucoma       Date:  2007-09       Impact factor: 2.503

8.  Depression and quality of life in patients with glaucoma: a cross-sectional analysis using the Geriatric Depression Scale-15, assessment of function related to vision, and the Glaucoma Quality of Life-15.

Authors:  Simon Skalicky; Ivan Goldberg
Journal:  J Glaucoma       Date:  2008 Oct-Nov       Impact factor: 2.503

9.  Depression and mood indicators in newly diagnosed glaucoma patients.

Authors:  Henry D Jampel; Kevin D Frick; Nancy K Janz; Patricia A Wren; David C Musch; Rajiv Rimal; Paul R Lichter
Journal:  Am J Ophthalmol       Date:  2007-06-11       Impact factor: 5.258

10.  Staging of functional damage in glaucoma using frequency doubling technology.

Authors:  Paolo Brusini; Claudia Tosoni
Journal:  J Glaucoma       Date:  2003-10       Impact factor: 2.503

View more
  31 in total

1.  Sensory impairments and their associations with functional disability in a sample of the oldest-old.

Authors:  Verena R Cimarolli; Daniela S Jopp
Journal:  Qual Life Res       Date:  2014-03-29       Impact factor: 4.147

2.  The Prevalence of Depression and Depressive Symptoms among Eye Disease Patients: A Systematic Review and Meta-analysis.

Authors:  Yajing Zheng; Xiaohang Wu; Xiaoming Lin; Haotian Lin
Journal:  Sci Rep       Date:  2017-04-12       Impact factor: 4.379

3.  Applying theories and interventions from behavioral medicine to understand and reduce visual field variability in patients with vision loss.

Authors:  Collin Rozanski; Jennifer A Haythornthwaite; Gislin Dagnelie; Ava K Bittner
Journal:  Med Hypotheses       Date:  2014-05-09       Impact factor: 1.538

4.  Risk factors for depressive symptoms in glaucoma patients: a nationwide case-control study.

Authors:  Chien-Chia Su; Judy Yi-Chu Chen; Tsing-Hong Wang; Jehn-Yu Huang; Chung-May Yang; I-Jong Wang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-06-07       Impact factor: 3.117

5.  Fast Visual Field Progression Is Associated with Depressive Symptoms in Patients with Glaucoma.

Authors:  Alberto Diniz-Filho; Ricardo Y Abe; Hyong Jin Cho; Saif Baig; Carolina P B Gracitelli; Felipe A Medeiros
Journal:  Ophthalmology       Date:  2016-02-23       Impact factor: 12.079

6.  Blindness and Visual Impairment in the Medicare Population: Disparities and Association with Hip Fracture and Neuropsychiatric Outcomes.

Authors:  Ali G Hamedani; Brian L VanderBeek; Allison W Willis
Journal:  Ophthalmic Epidemiol       Date:  2019-05-07       Impact factor: 1.648

7.  Quality of life of glaucoma patients in China: sociodemographic, clinical, and psychological correlates-a cross-sectional study.

Authors:  Chuandi Zhou; Shaohong Qian; Peixia Wu; Chen Qiu
Journal:  Qual Life Res       Date:  2013-09-24       Impact factor: 4.147

8.  Melanopsin-expressing retinal ganglion cell loss and behavioral analysis in the Thy1-CFP-DBA/2J mouse model of glaucoma.

Authors:  Qi Zhang; Helen Vuong; Xin Huang; YanLing Wang; Nicholas C Brecha; MingLiang Pu; Jie Gao
Journal:  Sci China Life Sci       Date:  2013-06-01       Impact factor: 6.038

9.  Trends in and Predictors of Depression Among Participants in the Collaborative Initial Glaucoma Treatment Study (CIGTS).

Authors:  David C Musch; Leslie M Niziol; Nancy K Janz; Brenda W Gillespie
Journal:  Am J Ophthalmol       Date:  2018-09-21       Impact factor: 5.258

10.  Prevalence and 11-year incidence of common eye diseases and their relation to health-related quality of life, mental health, and visual impairment.

Authors:  Petri K M Purola; Janika E Nättinen; Matti U I Ojamo; Seppo V P Koskinen; Harri A Rissanen; Päivi R J Sainio; Hannu M T Uusitalo
Journal:  Qual Life Res       Date:  2021-03-23       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.